Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of Iodine-131 Anti-B1 Antibody followed by
CHOP and to see what effects it has on patients with previously untreated mantel cell
lymphoma.